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ABSTRACT
Objective: Worry is an important perpetuating factor of Medically
Unexplained Symptoms (MUS). Former research has shown that a
worry postponement instruction is effective in reducing
Subjective Health Complaints (SHC) in non-clinical samples. This
study aimed to (1) replicate these findings in a MUS-analogue stu-
dent-sample and (2) assess alexithymia as a moderator.
Design: The current study had an experimental design with two
waves of data collection: pre- and post-intervention.
Main outcome measures: A MUS-analogue student-sample con-
sisting of 114 undergraduate students with high self-reported
health worry and a minimum of two doctor visits in the previous
year with no current diagnosis for a (chronic or acute) disease
were instructed to register their worry frequency and duration
eight times per day via an experience sampling-application on
their smartphones. The intervention group additionally postponed
their worries to a 30-minute period in the evening. SHC were
assessed pre- and post-intervention.
Results: The intervention did not have an effect on worry or SHC.
Alexithymia did not moderate this effect (p’s > .05).
Conclusion: Our study did not find evidence for the effectiveness
of the worry reduction intervention on SHC in a MUS-analogue
student-sample. This finding contributes to several previous stud-
ies that have found mixed evidence for the effectiveness of the
worry reduction intervention on SHC and suggests that the worry
intervention may not be effective in all cases.
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Subjective Health Complaints (SHC), such as fatigue, gastrointestinal problems and
musculoskeletal pain, are extremely common. In the Netherlands, SHC score second
place on the top 10 list of the most important reasons to consult a General
Practitioner (GP; Hammond, 1964; Picavet & Schouten, 2003; van de Lisdonk, van den
Bosch, Huygen, & Lagro-Janssen, 1999). One in five people presenting with such SHC
in primary care has Medically Unexplained Symptoms (MUS; Barsky & Borus, 1995; de
Waal, Arnold, Eekhof, & van Hemert, 2004). MUS are symptoms without a clear medical
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cause (Olde Hartman et al., 2013; van der Weijden, van Velsen, Dinant, van Hasselt, &
Grol, 2003). Consequently, GPs cannot adequately help people suffering from these
symptoms. This often results in unnecessary referrals to other medical professionals
and to unproductive medical procedures. Consequently, MUS are responsible for a
poor health-related quality of life and high health care costs (Tveito, Passchier,
Duivenvoorden, & Eriksen, 2004). Because of the lack of a medical cause for these
symptoms, cognitive-behavioural models are used to understand and to treat MUS.
These models describe predisposing and perpetuating psychosocial factors of MUS.
One important perpetuating factor for physical symptoms in MUS-patients is repetitive
negative thinking (Deary, Chalder, & Sharpe, 2007). Repetitive negative thinking (i.e.
worry and rumination) is defined as a thinking style focussing on problems (current,
past, or future) and negative experiences (past or anticipated). This thinking style is
characterised by being repetitive, intrusive, and difficult to disengage from. Also, peo-
ple experience this thinking style as unproductive and capturing their cognitive cap-
acity (Ehring et al., 2011).
Thinking in a repetitive negative way about a stressor has been identified as a
mechanism prolonging the effect of a stressor on somatic health (Brosschot & Thayer,
2004). Based on these findings, Brosschot, Gerin, and Thayer (2006) formulated the
‘perseverative cognition hypothesis’ which indicates that repetitive negative thinking
prolongs the physiological stress response and this in turn will lead to negative health
consequences, including SHC. In line with this hypothesis, repetitive negative thinking
is found to be associated directly with SHC such as fatigue, lower back pain and other
pains (Freeston et al., 1996; Verkuil, Brosschot, Meerman, & Thayer, 2012). In addition,
and importantly, such negative health consequences have been reported not only in
clinical samples but also in persons who worry and ruminate at a non-clinical level
(Brosschot & van der Doef, 2006).
The association between repetitive negative thinking and SHC inspired a study in
which the prospective relation between worry and SHC was assessed by testing the
efficacy of a simple worry postponement instruction in adolescents aged 15–19 years
(Brosschot & van der Doef, 2006). In this worry reduction intervention, participants
were instructed to only register their worries (control group) or to additionally post-
pone their worries to a 30-minute ‘worry-window’ in the evening (intervention group).
Results showed that participants in the intervention group reported significantly less
SHC and significantly shorter worry episodes. Similar results were obtained when the
worry reduction intervention was later tested among teachers and in a child commu-
nity sample, aged 9–13 years (Jellesma, Verkuil, & Brosschot, 2009; Verkuil et al., 2012).
However, a more recent study by Versluis, Verkuil, and Brosschot (2016) did not man-
age to replicate an effect of the worry reduction intervention on SHC. Versluis et al.
(2016) tested the efficacy of an online version of the worry reduction intervention in a
group of self-selected participants with a mean age of 36.23 (SD ¼ 12.96) from the
general population. The authors found that the participants who had received the
instruction to postpone their worries, did not report less SHC, nor a reduction in worry
frequency or worry duration, as compared to the control group.
In short, several studies have reported positive effects of the worry reduction inter-
vention on SHC in diverse populations. However, the results of Versluis et al. (2016)
suggest that the intervention may not work with every sample or with every method
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of sampling (e.g., on paper or online). Hence, it is important to identify when, for
whom and under what conditions the intervention works best. Such knowledge would
help to further optimise the worry reduction intervention and its application. So far,
studies have only focused on SHC. However, given that worry has also been identified
as a perpetuating factor for MUS, the worry reduction intervention might also prove
to be effective in people with MUS. Testing alternative interventions for MUS-patients
is important as the current treatment standard, Cognitive Behavioral Therapy (CBT;
Borkovec & Sharpless, 2004; Borkovec, Wilkinson, Folensbee, & Lerman, 1983), only
modestly improves symptoms and can only be delivered by a trained psychotherapist.
As MUS patients typically seek treatment for their physical complaints, a worry reduc-
tion intervention by the patient’s GP may be more acceptable for MUS-patients than
going to a psychotherapist for CBT.
In the current study, we included a MUS-analogue student sample with self-
reported symptoms that are indicative of at least a mild MUS subtype. The mild MUS
subtype includes patients that do not meet the formal DSM criteria for MUS diagnosis
but who fall on the clinical spectrum for MUS. These patients infrequently seek help
and reassurance for health-related worries concerning physical complaints for which
no apparent physical illness is identified and make up approximately 80% of all MUS
patients (Smith & Dwamena, 2007). The goal of our study was to assess the efficacy of
the worry reduction intervention on SHC in a MUS-analogue student sample covering
the lower end of the MUS spectrum.
To possibly further specify for whom the intervention may be effective, we included
alexithymia as a possible moderator of the efficacy of the worry reduction intervention
on SHC. Alexithymia is a personality trait, normally distributed across the general
population, which entails a difficulty in identifying and labelling emotions and accom-
panying bodily sensations and has been found to be related to both repetitive nega-
tive thinking and to SHC and MUS, which makes it a relevant trait for this particular
sample (Cohen et al., 1994; De Gucht, Fischler, & Heiser, 2004; Lumley et al., 1997;
Panayiotou et al., 2015; Taylor et al., 1992). More specifically, it could be that the diffi-
culty to identify and label bodily sensations in people with alexithymia may cause
them to worry about the possible origin of these undefined bodily sensations resulting
in further SHC. Furthermore, an inability to identify negative emotions and bodily sen-
sations that accompany repetitive negative thinking may make it more difficult for
individuals with alexithymia to identify and thus postpone their worrying. Hence, we
expect that people high in alexithymic traits will benefit less from the intervention as
compared to people low on alexithymic traits.
The present study used a similar experimental procedure as Brosschot and van der
Doef (2006) with one notable difference. In contrast to the paper and pencil method
that was used by Brosschot and van der Doef (2006) which asked participants to recall
how often and how much they were worrying during the day, the current study used
an Experience Sampling Method (ESM) to register worry. ESM is especially suitable for
assessing behaviour in student populations because of the availability and popularity
of smartphones (Free et al., 2013). ESM allows automated registration of the frequency
and duration of worries in a reliable and ecologically valid manner, without the down-
side of a recall bias (Shiffman, Stone, & Hufford, 2008).
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Method
Participants
Participants were undergraduate students who were selected via the online university
participation system if they (1) indicated a minimum of two doctor visits during the
previous year and (2) indicated a minimum score of 60 on a health worry-item: ‘I worry
about my health’ (ranging from 1 [never] to 100 [always]). We selected participants on
these two criteria as an average of two doctor visits and health-related worry are indi-
cative of at least mild MUS subtype (Olde Hartman et al., 2013; Smith & Dwawema,
2007). Participants were excluded from participation if they were currently in treat-
ment for a (chronic) disease that might account for elevated health complaints (e.g.,
heart disease and asthma). Participants were only included if they could understand
and write in Dutch and if they had an iOS or Android smartphone to their disposal for
the research period. The sample initially consisted of a total of 120 participants.1
Over the course of the study, six participants dropped out: because of college obli-
gations (n¼ 2), because the study became too much of an effort (n¼ 3) and for
unknown reasons (n¼ 1). In the end, a total of 114 participants (100 females) were
included for analyses. The mean age in the remaining group was 20.26 years (SD ¼
1.99). Drop-outs did not differ from the remaining participant group on the baseline
measures and drop-out was not related to condition (p’s > .05). All participants gave
written consent before participating. Participants received course credit or 30 euros in
vouchers for their participation.
Instruments
Experience-sampling application
Daily assessments were collected via an application for ESM (Real Life Exp Mobile app,
Lifedatacorp). Participants downloaded the application on their smartphones. The app
was programmed to randomly send participants eight notifications per day between
the hours of 08.00 and 22.00 during the six-day research period. Participants were
able to open the questionnaire by clicking on the notification. After arrival of the noti-
fication, participants had a 15-minute window to fill in the questionnaire. Time periods
between the notifications were programmed to a minimum of half an hour.
Worry frequency. At each notification, participants indicated whether they were wor-
rying at that moment (yes/no).
Worry duration. At each notification, participants estimated the number of minutes
they had been worrying during the half hour before filling in the questionnaire by
positioning a slider on a scale between 0 and 30minutes.
Paper questionnaires
Several paper questionnaires were administered pre-intervention (T1) and post-inter-
vention (T2).
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Trait-repetitive negative thinking. A general tendency to engage in repetitive nega-
tive thinking was measured with the Dutch version of the Perseverative Thinking
Questionnaire-15 (PTQ-15-NL; Ehring et al., 2011; x ¼ .93, CI [.92, .95]) and was admin-
istered pre-intervention. Omega-total is reported here, along with the CI, as research
has shown that reporting omega-total as an estimate for internal consistency will lead
to a more accurate and higher estimate of the internal consistency than Cronbach’s
alpha (see for a discussion; McNeish, 2017; Peters, 2014). Omega-total was estimated
using the userfriendlyscience package (version 0.7.1; Peters, 2018). The PTQ-15-NL con-
sists of 15 statements scored on a 5-point Likert-scale ranging from 0 (‘never’) to 4
(‘always’). A total sum score was obtained by adding up the scores on all items.
Higher scores indicate a higher tendency to engage in repetitive negative thinking.
Subjective health complaints. The Dutch version of the Subjective Health Complaints
Inventory (SHCI; Eriksen, Ihlebaek, & Ursin, 1999) was administered pre- (x ¼ .75, CI
[.68, .82]) and post-intervention (x ¼ .8, CI [.75, .86]). The SHCI reliably scores the num-
ber of somatic and psychological health complaints, as well as the duration of these
complaints. The SHCI consists of the 29 most common health complaints (domains:
musculoskeletal, pseudo-neurological, gastrointestinal complaints, allergy and the flu)
which are scored on a 4-point Likert-scale ranging from 0 (‘not at all’) to 3 (‘severely’).
Following Brosschot and van der Doef (2006), the total number of SHC in the past
week was used as the primary outcome variable in this study. Higher scores indicate a
higher number of SHC.
Alexithymia. To assess alexithymia, the Dutch version of the Bermond-Vorst
Alexithymia Questionnaire (BVAQ; Vorst & Bermond, 2001; x ¼ .87, CI [.73, .84]) was
used pre-intervention. The BVAQ consists of 40 statements to assess alexithymia in a
valid, reliable way. The statements are scored on a 5-point Likert-scale ranging from 1
(I totally agree) to 5 (I do not agree at all). A total sum score was obtained by adding
up the scores on all items. Higher scores indicate higher levels of alexithymia.
Subjective worry change. To assess how participants subjectively scored their worry
after the six-day period, participants rated how their worry had changed over the
week (i.e. ‘Over the last week, my worrying …’) on a Visual Analogue Scale ranging
from (became a lot less) to (became a lot more). A score was obtained by measuring
the length of the line a participant drew in centimetres starting at zero (has
not changed).
Worry window compliance. To assess to what extent participants in the intervention
group complied with the worry window every evening, participants answered the fol-
lowing question: ‘How many times have you succeeded to do a worry-window over
the last week?’, by choosing an option in the following range: 0–6 times.
Explorative questions. Several open questions were asked post-intervention to
explore how participants handled the intervention. Also, body awareness was meas-
ured at pre- and post-intervention with the BAQ (Shields, Mallory, & Simon, 1989) to
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explore the possibility that the intervention would increase body awareness in partici-
pants. None of these measures are discussed in the present paper.2
Procedure
Before coming to the lab, participants were randomly assigned to either the interven-
tion group (worry registrationþpostponement instruction) or to the control group
(worry registration), with a random number table generated by the block.random func-
tion from the psych package (version 1.1.11; Revelle, 2017). When participants arrived
at the lab for the baseline-measures (T1), the researcher explained the procedure and
gave participants instructions, not mentioning the study aim. Participants were under
the impression that the study goal was to register their worries. Participants filled out
the questionnaires (SHCI, PTQ-15-NL, BVAQ) and received instructions on how to regis-
ter their worries via the ESM-application. The intervention group received additional
instructions on how to postpone their worries during the day (see the explanation on
the intervention below). All participants received a verbal explanation of negative
repetitive thinking based on the definition of Ehring et al. (2011): Repetitive negative
thinking (i.e. worry and rumination) is defined as a thinking style focussing on prob-
lems (current, past or future) and negative experiences (past or anticipated). This
thinking style is characterised by being repetitive, intrusive and difficult to disengage
from. Also, people experience this thinking style as unproductive and capturing their
cognitive capacity. Participants started with the six-day research period after the day
on which they came to the lab for the pre-measure. On the day after the last registra-
tion day (T2), participants came to the lab for the post-measure, where they filled out
a set of questionnaires (SHCI, explorative questionnaire) and received a debrief-
ing letter.
Intervention
The worry reduction intervention was implemented as described by Brosschot and van
der Doef (2006). The participants in the intervention group were instructed to post-
pone their worrying every time they realised they were worrying during the day, to a
self-chosen 30-minute period late in the evening that they would reserve for worrying
(i.e. ‘worry-window’). These participants received the following instructions:
Every time you find yourself worrying or ruminating or thinking in a negative, repetitive
manner, please try your best to terminate these worries right away, and to ‘postpone’
them to a special, self-chosen 30-minute-time period in the evening that you will use to
worry. If you do not succeed right away, please try again.
The instruction to postpone worries is a key component of CBT for Generalised
Anxiety Disorder, which is called stimulus control (Borkovec & Sharpless, 2004;
Borkovec et al., 1983). Brosschot and van der Doef (2006) modified this instruction for
the purpose of their study, with the difference being that participants in their study
did not receive an instruction on the exact time of their worry-window. The current
study followed the procedure by Brosschot and van der Doef (2006) by letting partici-
pants choose the time of their worry window individually. In the case, participants
received an ESM notification in the worry-window or immediately after, they were
instructed to fill in the questions with regard to the half hour before the worry-
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window. Participants in the control group did not receive the instruction to postpone
their worries to a later worry window. They simply registered their worry frequency
and worry duration in response to the ESM notifications.
Data analysis
First, descriptive statistics of the dependent variables and baseline measures were
examined. Second, bivariate Pearson correlations of the dependent variables and base-
line measures were examined to explore the associations between these variables.
Third, assumptions regarding the distributions of the variables included in the final
model were checked. There were no violations regarding the assumptions of normality
and homoscedasticity, and there were no univariate outliers (Field, Miles, & Field,
2012). Fourth, independent samples t-test were conducted to see whether there were
differences between males and females on baseline measures. Fifth, a manipulation
check for the effect of the intervention on worry frequency and worry duration was
performed (in line with former research [e.g. Brosschot & van der Doef, 2006]) using t-
tests for independent samples. These preparatory steps were conducted using SPSS,
version 21.0 (IBM Corp, 2012).
To test the effect of the intervention on the number of SHC, to test alexithymia as
a moderator of this effect, and worry duration and worry frequency as mediators of
the effect, a final mediation/moderation-model was constructed. To prepare worry dur-
ation and worry frequency for inclusion in the final model, mixed-effects model analy-
ses were used to extract per-participant random slope coefficients of worry frequency
and worry duration. We chose to include per-participant random slope coefficients for
worry frequency and worry duration as mediators in the final model, because these
coefficients take the change over time into account. Mixed-effects models are the pre-
ferred choice in this case because of the nested structure of the daily worry assess-
ments and the differing number of unanswered notifications between participants. In
comparison to, for example, Repeated-Measures ANOVAs, mixed-effects models are
better suitable for handling unbalanced designs and they account for dependencies in
the data, which is especially important with ESM-data (Barr, Levy, Scheepers, & Tily,
2013). Mixed-effects models were estimated with the lmer and glmer functions from
the package lme4 (version 1.1.12; Bates, Maechler, Bolker, & Walker, 2015) in RStudio
(Rstudio, 2012), an integrated development environment for R (version 3.3.30; R Core
Team, 2017).
Before running the models, model diagnostics for the dependent variables included
in the mixed-effects models were examined following the recommendations of Bates,
Maechler, Bolker, and Walker (2014). There were no peculiarities regarding the model
diagnostics. Two mixed-effects models were tested to be able to extract random-slope
coefficients: one to assess the change in worry duration over time and one to assess
the change in worry frequency over time. The former included worry duration as the
dependent variable and the day of the week as the independent variable. The latter
included worry frequency as the dependent variable and the day of the week as the
independent variable.
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Finally, the mediation/moderation-model was tested. To assess the effect of the
intervention on the number of SHC, condition was added as the independent variable
and the change in number of SHC over time (SHC T2-T1) was included as the depend-
ent variable. Further, alexithymia was added as a moderator of this effect. The random
slope-coefficients for worry frequency and worry duration were added as mediators of
the effect. All predictors were centred within PROCESS. This analysis was performed
using the PROCESS macro for SPSS with bias-corrected 95% Confidence Intervals using
bootstrapping with 5000 resamples (model 5; Hayes, 2013). To control for the large
number of tests, the significance was set at p < .01.
Results
Descriptive statistics
The final sample consisted of 100 females and 14 males. The intervention group
(49 females, 8 males) and the control group (51 females, 6 males) both consisted
of 57 participants. Descriptive statistics of the baseline measures, pre-interven-
tion and post-intervention measures are presented per group in Table 1. The
average score on trait-repetitive negative thinking was 27.26 (SD¼ 10.42), which
is comparable to the mean scores of both a population without a disorder and a
population with another disorder than anxiety or depression (Ehring et al., 2011).
Male participants scored significantly higher on alexithymia (M¼ 102.54, SD ¼
28.50) compared to female participants (M¼ 87.80, SD ¼ 17.00), t(111)¼ –2.69, p
¼ .008. Men and women did not differ significantly on the other variables (all p’s
> .05).
Descriptive statistics of worry frequency and worry duration are presented in Table
2. No differences were found regarding the mean number of minutes worried on day
1 between the control group (M¼ 10.10, SD ¼ 6.79) and the intervention group
(M¼ 9.03, SD ¼ 6.56), p ¼ .236. Both groups showed an increase in worry duration
over the course of the week with a peak on day 6. No differences were found regard-
ing the mean worry frequency on day 1 between the intervention group (M¼ 6.27, SD
¼ 1.76) and the control group (M¼ 6.20, SD ¼ 2.11), p ¼ .451. Both groups showed a
decrease in worry frequency over the course of the week, with a steeper drop on day
6. The worry variables are visualised in Figures 1 and 2.
Table 1. Descriptive statistics of age, trait-perseverative negative thinking, alexithymia, and the
pre- and post-measure of subjective health complaints
Intervention group Control group
T1 T2 T1 T2
M SD M SD M SD M SD
Age 20.42 2.09 20.09 1.S9
Trait-PNT 28.30 9.53 26.20 11.24
Alexithymia 88.81 17.50 90.20 20.74
Number of SI-ICs 9.95 3.97 8.94 4.16 9.79 3.56 9.81 3.69
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Correlations
Bivariate correlations between all constructs are presented in Table 3. As can be seen
in Table 3, trait-repetitive negative thinking was positively associated with worry dur-
ation (r ¼ .35, p < .001) and worry frequency (r ¼ .25, p < .001), and with SHC, as
Table 2. Descriptive statistics of worry frequency and worry duration throughout the week.
Worry frequency Worry duration
Intervention
group Control group Intervention group Control group
M SD M SD M SD M SD
Day 1 6.27 1.76 6.20 2.11 9.03 4.51 10.10 4.14
Day 2 5.71 2.02 5.73 2.39 9.19 4.07 10.27 4.18
Day 3 5.46 2.34 5.73 1.94 9.48 4.41 10.52 5.89
Day 4 5.54 2.44 5.19 2.56 9.48 4.61 10.49 5.15
Day 5 5.45 2.64 5.64 2.54 10.27 5.96 12.26 5.59
Day 6 3.18 2.28 3.61 1.69 10.98 6.63 11.34 5.17
Figure 1. Mean worry duration in minutes per group over the course of the intervention period.
Figure 2. Mean number of worry episodes per group over the course of the intervention period.
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measured at T1 (r ¼ .36, p < .001) and at T2 (r ¼ .37, p < .001). In addition, worry fre-
quency related positively to SHC at T2 (r ¼ .21, p ¼ .028). Gender was positively
related to alexithymia (r ¼ .25, p ¼ .008), indicating that the male gender is related to
higher scores on alexithymia. The random slopes of worry duration and worry fre-
quency were not significantly related to the difference score of SHC (p ¼ .468 and p
¼ .084, respectively), indicating disconfirmation of our hypothesis that a change in
worry is related to a change in SHC.
Manipulation check
A t-test revealed that this version of the intervention did not have an effect on the
slopes of worry duration (t(107) ¼ 1.27; p ¼ .206; d ¼ .25) and worry frequency (t(107)
¼ .26; p ¼ .798, d ¼ .05). Thus, contrary to expectations, the intervention to postpone
worries to the evening did not reduce the frequency of worrying nor its duration in
the current sample.
Effect of time on the worry variables
Two mixed-effects models were tested to assess whether there was an effect of time
on worry duration and worry frequency using the lmer function and the glmer func-
tion of the lme4 package (version 1.1.12; Bates et al., 2015). The glmer function was
used with a Poisson distribution to estimate a mixed-effects model for worry fre-
quency, as worry frequency is a count variable and is estimated better when account-
ing for its non-normal distribution (Jaeger, 2008). The mixed-effects models included
worry duration and worry frequency as dependent variables, fixed effects for day of
the week and fixed intercepts. Also, a maximal random-effects structure was used, as
advised by Barr et al. (2013) to model the repeated-measures nature of the data, by
including random intercepts and random slopes of day of the week. Furthermore, all
possible random correlation terms among random effects were included. For the
worry duration model, p-values were determined using conditional F tests with
Table 3. Bivariate correlations between all constructs.
1. 2. 3. 4. 5. 6. 7. 8. 9. 10.
1. Gendera
2. Trait-UMb -.16
3. Alexithymia .25 .02
4. Subjective change in Worry .06 .14 .02
5. Slope durationc .03 .17 .06 .12
6. Slope frequencyd -.05 .10 -.02 .20 .33
7. SHC T1 -.11 .36 .04 -.06 .07 .12
8. SHC T2 -.20 .37 -.01 .19 .12 .23 .70
9. SHC T2–T1 -.02 .06 -.02 .34 .07 .17 -.33 .44
10. Worry duratione .09 .35 .00 .18 .59 .13 .06 .11 -.14
11. Worry frequencyf .03 .254 .11 .13 -.07 .31 .18 .21 .01 .04
a1¼ female and 2¼male.
bRNT¼ repetitive negative thinking.
c,dPer-participant random slopes for worry duration and worry frequency.
e,fMean worry duration and mean worry frequency per participant.p < .05.p < .01.
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Kenward-Roger correction for degrees of freedom, with the ANOVA function (using
Type III F tests; car package, version 2.1.2; Fox & Weisberg, 2011) which in turn calls
the KRmodcomp function (pbkrtest package, version 0.4.6; Halekoh & Højsgaard,
2014). For the worry frequency model, the anova function (base package, R Core
Team, 2017) was used which uses Likelihood Ratio Tests to determine p-values.
The results of the mixed-effects model for worry duration showed a significant
change of worry duration over time (B¼ 0.343, SE ¼ 0.11, F(5, 93.42) ¼ 3.32, p ¼ .008).
This indicates that over the days of the week, contrary to our expectation, worry dur-
ation increased, as can be seen in Figure 1 (see Table 2 for descriptive statistics per
day and per group). Figure 2 shows a decreasing trend of worry frequency over the
days of the week for both groups. However, the results of the mixed-effects model for
worry frequency showed a non-significant change of worry frequency over time (B ¼
–.024, SE¼ 0.01; v2 (1) ¼ 3.02, p ¼ .090).5 This indicates that over the days of the
week, worry frequency did not change. Per-participant coefficients were subtracted for
both models (coef. function, base package, R Core Team, 2017), to add them as pre-
dictors in the mediation model.
Effect of the worry reduction intervention on SHC
First, a repeated-measures analysis revealed a non-significant TimeGroup interaction
effect on SHC (F(1, 105) ¼ 1.51; p ¼ .223; g2 ¼ .01). Next, the final moderation-model
was created and tested within PROCESS (Hayes, 2013), despite the absence of a direct
effect of the intervention on SHC, following the advice of many authors (e.g., Hayes,
2009; MacKinnon et al., 2000; Shrout & Bolger, 2002). The model included group (inter-
vention group/control group) as the independent variable, the difference score of SHC
(T2–T1) as the outcome variable, alexithymia as a moderator, the random slope coeffi-
cients of worry duration and worry frequency as mediators, and gender, trait-repetitive
negative thinking and worry-window compliance as control variables. However, none
of the tested predictors or paths were significant (p’s > .05, R2 ¼ .04; see Table 4 for
coefficients for each of the predictors and paths). Thus, no evidence was found that
the intervention has an effect on the number of SHC. Furthermore, alexithymia was
Table 4. Moderation model results for all predictors, the moderator and for the two mediators in
the model for the effect on the difference score of SHCa (T2.17).
Predictor SE 9 5Cis P
Group (intervention/control) .34 .30 –.25, .92 1.13 .259
Alexithymia –.10 .30 –30, .50 –.32 .746
Worry durationb –.05 .31 –.67, .57 –.16 .877
Worry frequencyb .56 .32 –.07, 1.18 136 .082
Gender –.01 .34 –.69, .66 –.04 .967
Trait-RNTc .13 .30 –.47, .74 .44 .660
Worry-window compliance .15 .22 –.41, .63 .41 .442
Group  Alexithymia .32 .30 –.28, .93 1.06 .291
Indirect effect Worry duration –.01 .06 –. 1.7, .10
Indirect effect Worry frequency .03 .07 –.07, .22
aSHC – Subjective Health Complaints.
bPer-participant slope coefficients for worry duration and worry frequency.
cTrait-Repetitive Negative Thinking.
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not a moderator of the relationship, and worry frequency and worry duration were
not mediators of the relationship; the model did not fit the data.
Discussion
In the current study, we aimed to test the effectiveness of the worry reduction inter-
vention in reducing worry and SHC in a MUS-analogue student-sample. No evidence
was found that the manipulation works: the intervention did not reduce worry dur-
ation nor worry frequency in this study. The intervention also did not have an effect
on SHC. Moreover, worry frequency did not change over time, whereas worry duration
did. The change in worry duration over time was not related to the change in SHC
score from pre- to post-measure. We replicated the finding that participants who
scored high on trait-repetitive negative thinking also reported more SHC, as predicted
by the perseverative cognition hypothesis. Also, alexithymia did not moderate the rela-
tion between the intervention and SHC. Lastly, worry frequency and worry duration
did not mediate the relation between the intervention and SHC. In short, this study
did not find evidence to support the effectiveness of the six-day version of the worry
reduction intervention in reducing neither worry, nor SHC in the current sample.
These findings are in line with a recent study by Versluis et al. (2016) that also
could not replicate the effect of the intervention on both worry and SHC. The present
study thus adds to the evidence that the intervention may not always be effective in
every population. The present study and the study by Versluis et al (2016) appear to
conflict with several earlier studies in which the intervention was found to be effective
in reducing worry (Brosschot & van der Doef, 2006; Jellesma et al., 2009). In this
regard, it is relevant to note that Brosschot and van der Doef (2006) only found a mar-
ginally significant effect of the worry reduction intervention on worry frequency
(Brosschot & van der Doef, 2006). This indicates that the effect of the intervention is
not consistent across studies.
An explanation for the lack of evidence for an effect of the worry reduction inter-
vention might involve the characteristics of the sample. The students in our analogue
MUS-sample were selected on the basis of their high levels of health-related worry
and on their relatively high number of doctor visits. In contrast, former studies have
mostly included samples from the general population with relatively low worry scores
(Brosschot & van der Doef, 2006; Jellesma et al., 2009; Verkuil et al., 2012). Hence, a
possible explanation is that the worry intervention may only be effective in individuals
with a low tendency to worry. The results of Versluis et al. (2016) are consistent with
this interpretation as this study also did not find an effect of the intervention on worry
duration, worry frequency and SHC in a population with relatively high scores on trait-
worry. A possible explanation might be that for samples with relatively high tendency
to worry, the intervention is perhaps not elaborate enough, or is too short to reduce
the relatively high levels of worry and SHC. This explanation is supported by the data
in Figure 1: there is a stabilisation/decrease in worry duration after day 5, which could
indicate a decreasing trend after day 5. Also, Table 2 shows that the intervention
group did show a slight decrease in SHC from pre- to post-intervention. These trends
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might be revealed by a longer assessment period and strengthened by a longer inter-
vention period.
A second explanation might involve the worry content. The current sample was
selected on high health-related worry, in contrast to samples in earlier research which
were not selected on worrying (e.g., Brosschot & van der Doef, 2006; Verkuil et al.,
2012). It could be that worrying about issues related to work, study obligations or rela-
tionships are easier to postpone than health-related worries, because health worries
might be triggered by one’s current physical condition. For example, if a person suf-
fers from lower back pain, he or she might find it hard to postpone his or her worries
about the pain when currently experiencing pain. In line with this idea, Eccleston and
Crombez (2007) indicate that (chronic) pain is hard-wired to capture attention, may
increasingly trigger worry and distress, and even result in hypervigilance for pain.
Future research should include additional measures that assess experience of pain, as
well as the success of participants to effectively postpone their worries, to investigate
this hypothesis.
A third explanation might lie in the choice of the criterion for success. We have
chosen, in line with former research, to assess the number of SHC from pre- to post-
intervention. One characteristic of MUS-patients on the low end of the spectrum is
that they do not necessarily have a lot of complaints, but rather that they have some
SHC that are very persistent and bothersome. As our sample included MUS-analogue
students, it might be that the intensity of their SHC has changed, rather than the num-
ber of their SHC. For example, if a MUS-patient is experiencing lower back pain, the
intervention might cause the pain to become less intense, instead of causing it to dis-
appear entirely. This explanation remains speculative, because the current study did
not include any measures that can support this claim. Future research should take
into account the intensity/severity of SHC to assess this explanation.
We found an increase in worry duration over time for both groups, which is in the
opposite direction of what is usually found in this line of research. There are several
explanations that may be considered for this unexpected finding. First, participants were
instructed to fill out a minimum of 38 notifications (from a total of 48 notifications)
throughout the week to get full course credit or vouchers. This instruction was intended
to motivate participants to register their worries. However, this instruction might have
caused participants to worry about whether they registered their worries often enough.
This explanation is supported by the fact that multiple participants gave verbal feedback
to the researcher that this occupied their minds during the week.
A second explanation might pertain to the methods that were used in this study. In
this study, an ESM-application was used to send participants eight notifications per
day to register their worries. ESM is known to be more intrusive than paper-pencil
methods (Scollon, Kim-Prieto, & Diener, 2003). The notifications might have served as
reminders for the participants that they were worrying. As a consequence, participants
might have become more sensitised to the fact that they were worrying and may
have worried about how much they were worrying, as can be explained by the litera-
ture on measurement reactivity: Responding to repeated measurements regarding
cognitions or worries has the effect of creating new thoughts, including worries
(Darker & French, 2009; French, Cooke, McLean, Williams, & Sutton, 2007; French &
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Sutton, 2010). This explanation is supported by the fact that the increase in worry dur-
ation was observed in both groups. However, an increase in negative emotions or
worrying has been found to usually resolve within two or three days (see for a discus-
sion, French & Sutton, 2010).
The current study had several strengths and limitations that are worth mentioning.
First, this study included ESM to assess worry frequency and worry duration. Former
research mostly used paper-pencil tasks, which have the drawback of introducing
recall bias. ESM assesses the variables of interest in a more reliable way (Shiffman
et al., 2008). However, as noted above, sampling of worry via ESM may have the
downside of enhancing worry, as may have been the case in the present study.
Second, in contrast to earlier studies, this study included a worry-window compliance
measure, which was added as a control variable in the analyses. However, as our com-
pliance measure was a one-time measure at the end of the intervention period, we
recommend that future research includes a daily compliance measure. This would give
a more precise indication of worry-window compliance. A limitation of our study is
that our study sample was characterised by an underrepresentation of males: only
12% of the participants were male. The underrepresentation of males is quite common
in research into repetitive negative thinking (e.g., Wittchen, Zhao, Kessler, & Eaton,
1994). In the present study, no effects of gender were found in the distributions of
the dependent variables, which suggest that gender effects did not play a prominent
role in the outcome of the study. We did find that male participants scored higher on
alexithymia which is a normal finding in the alexithymia literature (e.g., Taylor
et al., 1992).
In conclusion, this study suggests that students with SHC and health worries ana-
logue to MUS-patients do not necessarily benefit from a six-day version of a worry-
postponement intervention. Thereby this paper casts further doubt on the applicability
of the worry reduction intervention as a general tool that is effective in all cases
where repetitive negative thinking may influence health. However, one must view
these conclusions in the light of the study’s limitations. Therefore, taking these limita-
tions in mind, we still consider the worry reduction intervention as a potentially fruitful
and effective technique to reduce repetitive negative thinking, SHC, and stress-related
disease. It is important that future research invests in determining the factors that
enable or prevent the worry reduction intervention to be effective such as individual
differences in worry tendencies, effects of measurement or sampling method, the
influence of pain or worry about health-related problems, duration of the intervention
and instructions for compliance. It is our hope that these and related initiatives will
contribute to a better understanding and treatment of SHC.
Notes
1. The sample size of 120 participants was determined a priori using GPower (Faul,
Erdfelder, Lang, & Buchner, 2007) with a 95% chance to detect a small effect size (d¼ 0.2;
based on Brosschot & van der Doef, 2006) at an alpha level of .05.
2. These measures were included as part of a separate research question and will be
discussed elsewhere. The data on these measures is available upon request from
the authors.
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3. Calculating and reporting effect sizes for mixed-models is currently still problematic and
under debate (see for a discussion, Kramer, 2005). However, the coefficient can be
interpreted as an unstandardized effect index. B¼ 0.34 in this case means that for every
one unit increase, so each day of the week, worry duration increased by 0.34minutes
(20.4 seconds) for the entire sample.
4. B ¼ –.02 in this case means that for every one unit increase, so each day of the week,
worry frequency decreased by -.02 episodes for the entire sample (not-significant).
5. Exploratory correlation analysis indicated that there was no correlation between worry
frequency and worry duration (r ¼ .04) suggesting that there was no trade-off between
the two worry measures. Future research may in fact combine worry duration and worry
frequency in a single estimate of time spend worrying in order to rule out trade-off effects
and obtain a single measure reflecting the amount of repeated negative thinking.
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